Caris Life Sciences Statistics Share Statistics Caris Life Sciences has 281.27M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 281.27M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 4,294 FTD / Avg. Volume 0.37%
Short Selling Information The latest short interest is 1.29M, so 0.47% of the outstanding
shares have been sold short.
Short Interest 1.29M Short % of Shares Out 0.47% Short % of Float 0.92% Short Ratio (days to cover) 2.26
Valuation Ratios The PE ratio is -25.3 and the forward
PE ratio is 125.25.
Caris Life Sciences's PEG ratio is
-0.52.
PE Ratio -25.3 Forward PE 125.25 PS Ratio 17.3 Forward PS 10.9 PB Ratio -2.85 P/FCF Ratio -28.11 PEG Ratio -0.52
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Caris Life Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.3,
with a Debt / Equity ratio of -0.17.
Current Ratio 1.3 Quick Ratio 1.06 Debt / Equity -0.17 Debt / EBITDA -2.32 Debt / FCF -1.67 Interest Coverage -5.14
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $233.05K Profits Per Employee $-159.35K Employee Count 1,769 Asset Turnover 1.2 Inventory Turnover 5.9
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0, so Caris Life Sciences's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) 68.82 Average Volume (20 Days) 1,165,338
Income Statement In the last 12 months, Caris Life Sciences had revenue of 412.26M
and earned -281.89M
in profits. Earnings per share was -2.7.
Revenue 412.26M Gross Profit 178.78M Operating Income -257.12M Net Income -281.89M EBITDA -182.95M EBIT -231.87M Earnings Per Share (EPS) -2.7
Full Income Statement Balance Sheet The company has 63.95M in cash and 424.26M in
debt, giving a net cash position of -360.31M.
Cash & Cash Equivalents 63.95M Total Debt 424.26M Net Cash -360.31M Retained Earnings -2.47B Total Assets 3.27B Working Capital -95.89M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -245.2M
and capital expenditures -8.44M, giving a free cash flow of -253.64M.
Operating Cash Flow -245.2M Capital Expenditures -8.44M Free Cash Flow -253.64M FCF Per Share -1
Full Cash Flow Statement Margins Gross margin is 43.37%, with operating and profit margins of -62.37% and -68.38%.
Gross Margin 43.37% Operating Margin -62.37% Pretax Margin -68.38% Profit Margin -68.38% EBITDA Margin -44.38% EBIT Margin -62.37% FCF Margin -61.53%
